|
2025
|
P/S
|
Pharmaceutical preparations for prevention or treatment of infectious diseases Providing medical ... |
|
|
P/S
|
Pharmaceutical preparations for the treatment and prevention of infectious diseases Providing med... |
|
|
P/S
|
Pharmaceutical preparations for the treatment and prevention of bone, cardiovascular, central ner... |
|
|
P/S
|
Pharmaceutical preparations for the treatment and prevention of Pharmaceutical preparations for t... |
|
|
P/S
|
Pharmaceutical preparations, namely, anti-infectives and antivirals |
|
2024
|
P/S
|
pharmaceutical preparations for veterinary use, namely, anti-inflammatories, insecticides, and ho... |
|
|
P/S
|
Pharmaceutical preparations for use in Oncology |
|
|
P/S
|
Pharmaceutical preparations for use in oncology |
|
|
Invention
|
2-amino-n-heteroaryl-nicotinamides as nav1.8 inhibitors.
Novel compounds of the structural formu... |
|
|
P/S
|
Pharmaceutical preparations for the treatment of cancer |
|
|
Invention
|
Peptide conjugate vaccine compositions and methods for the treatment of alzheimer's disease.
The... |
|
|
Invention
|
Peptide conjugate vaccine compositions and methods for the treatment of alzheimer's disease. The ... |
|
|
Invention
|
Methods for treatment and prophylaxis of hiv and aids.
The present invention is directed to meth... |
|
|
Invention
|
Lyosphere critical reagent kit.
The present invention provides lyophilized pellets of low concen... |
|
|
Invention
|
Pyrrolidinyl derivatives useful as hcn1/hcn 2 modulators. The disclosure also relates to methods ... |
|
|
Invention
|
A cyclic peptide for trapping interleukin-1 beta. Provided are compounds of the Formula (I), or t... |
|
|
Invention
|
Cyclic peptide for trapping interleukin-1 beta.
Provided are compounds of the Formula (I), or th... |
|
|
Invention
|
Treatment of migraine.
The present disclosure provides methods for the acute treatment of migrai... |
|
|
Invention
|
Ripk1 inhibitors and methods of use. Described herein are compounds of Formula (I) or a pharmaceu... |
|
|
Invention
|
Human nectin-4 binders. The present disclosure provides isolated antibodies that specifically bin... |
|
|
Invention
|
Clogging prevention of needle-based delivery devices. An injection device includes a reservoir fo... |
|
|
Invention
|
Anti-cd27 antibody cell-based biological potency assay. This disclosure relates generally to a ce... |
|
|
P/S
|
Pharmaceutical preparations for the prevention and treatment of bone, cardiovascular, central ner... |
|
|
Invention
|
Use of an immunoconjugate for the treatment of endometrial cancer. The present disclosure relates... |
|
|
Invention
|
Ripk1 inhibitors and methods of use.
Described herein are compounds of Formula I
Described her... |
|
|
Invention
|
Ripk1 inhibitors and methods of use. Described herein are compounds of Formula I (I), or a pharma... |
|
|
Invention
|
Agglomerated crystalline medium chain fatty acid salts. The present disclosure provides compositi... |
|
|
Invention
|
Small molecule inhibitors of kras proteins.
Compounds of Formulae (I)-(VII) or their pharmaceuti... |
|
|
Invention
|
Small molecule inhibitors of kras proteins. Compounds of Formulae (I)-(VII) or their pharmaceutic... |
|
|
Invention
|
Devices for use as blood brain barrier models.
In some embodiments, devices for use as blood-bra... |
|
|
Invention
|
Il4i1 inhibitors and uses thereof. The present disclosure is directed to compounds of Formula I: ... |
|
|
Invention
|
Pharmaceutical compositions containing doravirine and islatravir. The instant invention relates t... |
|
|
Invention
|
Immunoassay for detecting tau phosphorylated at serine 413. Human tau protein phosphorylated at t... |
|
|
Invention
|
Use of an immunoconjugate for the treatment of non-small cell lung cancer. The present disclosure... |
|
|
Invention
|
Azaindazole derivatives useful as hcn2 modulators. The disclosure also relates to methods for use... |
|
|
Invention
|
Treating locally advanced or metastatic urothelial cancer with anti-191p4d12 antibody drug conjug... |
|
|
Invention
|
Platform for analysis of high-throughput sequencing data.
A sequencing data analysis platform ca... |
|
|
Invention
|
A raman spectroscopy method for monitoring and feedback control of perfusion cell culture. The pr... |
|
|
Invention
|
Stable formulations of anti-ctla4 antibodies alone and in combination with programmed death recep... |
|
|
Invention
|
Combination therapy of a pd-1 antagonist and lag3 antagonist for treating patients with cancer be... |
|
|
Invention
|
Methods to control polysorbate degradation in biotherapeutic formulations. The disclosure provide... |
|
|
Invention
|
Sustained-release formulations for poorly permeable cyclic peptides. The present disclosure provi... |
|
|
Invention
|
Inhibitors of human respiratory syncytial virus and metapneumovirus.
The present disclosure is d... |
|
|
Invention
|
Inhibitors of human respiratory syncytial virus and metapneumovirus. The present disclosure is di... |
|
|
Invention
|
Methods for detecting pcr chimeras. The present disclosure relates to methods for detecting PCR c... |
|
|
Invention
|
Lipolytic activity assay. Methods for rapidly measuring the level of active enzymes within an mAb... |
|
|
Invention
|
Multiproduct resin reuse (mrr) for the development and clinical manufacture of therapeutic protei... |
|
|
Invention
|
Monovalent interleukin 12 (il-12) heterodimeric fc proteins. Monovalent IL-12 heterodimeric Fc pr... |
|
|
Invention
|
Monovalent interleukin 12 (il-12) heterodimeric fc proteins.
Monovalent IL-12 heterodimeric Fc p... |
|
|
Invention
|
Anti-tigit antibodies.
The present invention relates to anti-TIGIT antibodies, as well as use of... |
|
|
P/S
|
pharmaceutical preparations, namely, anti-infectives and antivirals providing medical information... |
|
|
P/S
|
pharmaceutical preparations, namely, anti-infectives and antivirals; human vaccine preparations p... |
|
|
P/S
|
Pharmaceutical preparations, namely, anti-infectives and antivirals providing medical information... |
|
|
Invention
|
Newcastle disease viruses and uses thereof.
Described herein are chimeric Newcastle disease viru... |
|
|
P/S
|
Pharmaceutical preparations for the treatment of respiratory, gynecological, and neurological dis... |
|
2023
|
P/S
|
Providing medical information relating to cancer Personal support services for cancer patients, n... |
|
|
P/S
|
Pharmaceutical preparations for the prevention and treatment of cancer |
|
|
Invention
|
Plasma kallikrein inhibitors.
The present invention provides a compound of Formula (I) and pharm... |
|
2022
|
Invention
|
Substituted benzothiophene derivatives and methods of use thereof.
Provided are novel Substitute... |
|
|
Invention
|
Biomarkers for predicting eligibility for an anti-ilt4 and anti-pd-1 combination therapy.
Disclo... |
|
|
Invention
|
Pyrazolopyrimidine derivatives and methods of use thereof for the treatment of herpesviruses.
Pr... |
|
|
Invention
|
Antimalarial agents.
Provided are methods of treating malaria comprising administration of compo... |
|
|
Invention
|
Methods for treating acute myeloid leukemia with anti-ilt3 antibodies.
This disclosure relates t... |
|
|
Invention
|
Methods for treating cancer with subcutaneous administration of anti-pd1 antibodies.
The inventi... |
|
2021
|
Invention
|
Insulin receptor partial agonists.
Insulin dimers and insulin analog dimers that act as partial ... |
